Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Jiangsu Hengrui Medicine Co Ltd Announces Change in Accounting Policy


Monday, 1 Apr 2013 08:00pm EDT 

Jiangsu Hengrui Medicine Co Ltd announced that it will change its accounting policy, regarding the accounting estimate of accounting receivable bad debt provision, effective January 1, 2012. 

Company Quote

37.9
-0.3 -0.79%
23 Oct 2014